M-Health Care for Patients After AMI on Disease Perception, Self-Efficacy, Anxiety and Cardio-Respiratory Fitness

Sponsor
National Defense Medical Center, Taiwan (Other)
Overall Status
Recruiting
CT.gov ID
NCT04438356
Collaborator
(none)
80
1
2
26.4
3

Study Details

Study Description

Brief Summary

The aim of this study is to explore the overall effectiveness of interventions using mobile health care to improve disease perception, self-efficacy, anxiety, cardio-pulmonary fitness for patients with acute myocardial infarction.

Condition or Disease Intervention/Treatment Phase
  • Combination Product: M-Health
N/A

Detailed Description

Heart disease is the second leading cause of death in Taiwan. Coronary artery disease (CAD) is the majority, and coronary artery disease is the most common cardiovascular disease. There is an increase, and it is no longer just that the elderly is the predominant group. There is a tendency to gradually become younger. In foreign countries, coronary heart disease is also one of the main causes of patient death and disability, resulting in huge medical burdens and costs. Coronary heart disease also includes acute myocardial infarction, which causes myocardial cell death due to unstable myocardial ischemia. Sudden heart disease brings unexpected shock, fear, and despair to patients and their families. Therefore, patient self-management is very important. It also improves the patient's quality of life.

Post-acute myocardial infarction patients are susceptible to piecemeal information and lack the motivation to change their life style, continue to maintain smoking behavior and do not engage in exercise, leading to the recurrence of major coronary artery problems. In order to reduce secondary cardiovascular problems, it is necessary to rely on the patient's own knowledge of the disease, self-care behavior and self-efficacy, including diet, exercise, etc., so that the disease can be controlled and treated, and also need to monitor and adjust the physical and mental state to reduce subsequent problems caused by anxiety. Therefore, in order to provide multi-party support for patients' self-health care, mobile health care such as mobile phone text messages, applications, and remote monitoring are gradually emerging. Therefore, it is expected that the use of mHealth can be used to develop two-way communication and interaction and a higher message reception rate to stimulate acuteness. After myocardial infarction, patients can change their motivations for self-health care behaviors to achieve more efficient disease perception, self-efficacy, anxiety and cardiopulmonary fitness, and have a longer-term influence ability.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
wait list control group RCTwait list control group RCT
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Effects of Mobile Health Care for Patients After Acute Myocardial Infarction on Disease Perception, Self-Efficacy, Anxiety and Cardio-Respiratory Fitness: A Randomized Controlled Trial
Actual Study Start Date :
Jul 22, 2020
Anticipated Primary Completion Date :
Jun 20, 2022
Anticipated Study Completion Date :
Oct 5, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: M-health

After the acute myocardial infarction, patients will be randomly assigned to the intervention group. Give the intervention group mobile health care programs and given Garmin monitoring hands ring. In order to give patients clear walking goals and exercise intensity, the intervention group will use the Mobile Health Medical Line app to remind patients of the walking frequency and time, and use Garmin monitoring bracelet to record the patient's daily walking steps. The Mobile Health Medical Line app content includes: 1. Encourage the walking exercise to perform 2. Give them knowledge about acute myocardial infarction 3. How to self-care themselves 4. How to release their anxiety?

Combination Product: M-Health
The study was randomized (wait-list-control), and it was estimated that 80 subjects were randomly assigned to the immediate treatment group and the wait-list-control group. The two groups were tested for baseline before intervention in the mHealth. After the first questionnaire evaluation, the experimental group was involved in the mHealth for three months, and after three months, the experimental group and the waiting intervention control group were post-tested. To assess the effectiveness of the two groups before and after the mHealth . Control group that waits for intervention in the fourth month from the beginning of the fourth month to the end of the sixth month.

Experimental: wait list control

wait list control for 3 months and then use the Mobile Health Medical Line app to remind patients of the walking frequency and time, and use Garmin monitoring bracelet to record the patient's daily walking steps. The Mobile Health Medical Line app content includes: 1. Encourage the walking exercise to perform 2. Give them knowledge about acute myocardial infarction 3. How to self-care themselves 4. How to release their anxiety?

Combination Product: M-Health
The study was randomized (wait-list-control), and it was estimated that 80 subjects were randomly assigned to the immediate treatment group and the wait-list-control group. The two groups were tested for baseline before intervention in the mHealth. After the first questionnaire evaluation, the experimental group was involved in the mHealth for three months, and after three months, the experimental group and the waiting intervention control group were post-tested. To assess the effectiveness of the two groups before and after the mHealth . Control group that waits for intervention in the fourth month from the beginning of the fourth month to the end of the sixth month.

Outcome Measures

Primary Outcome Measures

  1. Disease Perception-T1 [T1-baseline]

    The Brief Illness Perception Questionnaire(The B-IPQ) have nine questions on the scale. The first eight questions use a response level of 0 to 10. The ninth question is an open question and answer. The patient is asked to list the three most important causes of the disease. The higher the total score, the greater the threat to the disease.

  2. Disease Perception-T2 [T2-three months later]

    The Brief Illness Perception Questionnaire(The B-IPQ) have nine questions on the scale. The first eight questions use a response level of 0 to 10. The ninth question is an open question and answer. The patient is asked to list the three most important causes of the disease. The higher the total score, the greater the threat to the disease.

  3. Disease Perception-T3 [T3-six months later]

    The Brief Illness Perception Questionnaire(The B-IPQ) have nine questions on the scale. The first eight questions use a response level of 0 to 10. The ninth question is an open question and answer. The patient is asked to list the three most important causes of the disease. The higher the total score, the greater the threat to the disease.

  4. Self-Efficacy-T1 [T1-baseline]

    Cardiac Self-Efficacy Scale have 13 questions in total. The higher the total score, the higher the patient's confidence in dealing with their own heart disease.

  5. Self-Efficacy-T2 [T2-three months later]

    Cardiac Self-Efficacy Scale have 13 questions in total. The higher the total score, the higher the patient's confidence in dealing with their own heart disease.

  6. Self-Efficacy-T3 [T3-six months later]

    Cardiac Self-Efficacy Scale have 13 questions in total. The higher the total score, the higher the patient's confidence in dealing with their own heart disease.

  7. Anxiety-T1 [T1-baseline]

    Beck Anxiety Inventory(BAI) have 21 questions in total. Each question is evaluated with 0-3 points for its severity, with a score of 0- 9 points are normal, 10-18 points are mild anxiety, 19-29 points are moderate anxiety, and 30 points or more are severe anxiety.

  8. Anxiety-T2 [T2-three months later]

    Beck Anxiety Inventory(BAI) have 21 questions in total. Each question is evaluated with 0-3 points for its severity, with a score of 0- 9 points are normal, 10-18 points are mild anxiety, 19-29 points are moderate anxiety, and 30 points or more are severe anxiety.

  9. Anxiety-T3 [T3-six months later]

    Beck Anxiety Inventory(BAI) have 21 questions in total. Each question is evaluated with 0-3 points for its severity, with a score of 0- 9 points are normal, 10-18 points are mild anxiety, 19-29 points are moderate anxiety, and 30 points or more are severe anxiety.

  10. Cardio-Respiratory Fitness-T1 [T1-baseline]

    Six-Minutes Walking Test, 6MWT

  11. Cardio-Respiratory Fitness-T2 [T2-three months later]

    Six-Minutes Walking Test, 6MWT

  12. Cardio-Respiratory Fitness-T3 [T3-six months later]

    Six-Minutes Walking Test, 6MWT

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Taiwanese, understand Chinese

  • Patients who are over 20 years old and have AMI (including ST segment ascending and non-ST segment ascending), diagnosed by percutaneous coronary intervention and without complications within 30±5 days, the left ventricular injection rate is greater than 40% .

  • Ability and willingness to provide informed consent.

  • Have a smartphone.

  • Can receive and send smartphone messages.

Exclusion Criteria:
  • Those who can't express their wishes clearly (such as mental dysfunction)

  • mental disorder

  • Patients who participate in other research projects

  • Planned coronary artery bypass surgery or other diseases that require continuous heart care.

  • Abuse of alcohol or narcotics.

  • Left ventricular ejection fraction (LVEF) is less than 40%.

Contacts and Locations

Locations

Site City State Country Postal Code
1 TSGH Taipei city Taiwan

Sponsors and Collaborators

  • National Defense Medical Center, Taiwan

Investigators

  • Principal Investigator: Hui-Hsun Chiang, PhD, National Defense Medical College, Japan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hui-Hsun Chiang, Associate Professor, National Defense Medical Center, Taiwan
ClinicalTrials.gov Identifier:
NCT04438356
Other Study ID Numbers:
  • M-Health Care for AMI Patients
First Posted:
Jun 18, 2020
Last Update Posted:
Sep 1, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hui-Hsun Chiang, Associate Professor, National Defense Medical Center, Taiwan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 1, 2021